Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Liver Transplantation in Long-term”

37 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 37 results

Large-scale testing (Phase 3)Study completedNCT01888432
What this trial is testing

Efficacy and Safety of Everolimus in Liver Transplant Recipients of Living Donor Liver Transplants

Who this might be right for
Liver Transplantation
Novartis Pharmaceuticals 285
Testing effectiveness (Phase 2)UnknownNCT01198314
What this trial is testing

Withdrawal of Immunosuppression in Long Term Stable Liver Transplant Recipients

Who this might be right for
Liver Transplantation
The Catholic University of Korea 20
Post-approval studies (Phase 4)Study completedNCT05152628
What this trial is testing

Modigraf® (Tacrolimus Granules) to Evaluate the Pharmacokinetics and Long-term Safety and Efficacy in De Novo Pediatric Allograft Liver and Kidney Transplantation Recipients

Who this might be right for
Liver TransplantationKidney Transplantation
Astellas Pharma China, Inc. 55
Testing effectiveness (Phase 2)Study completedNCT00282256
What this trial is testing

A Modified-Release Tacrolimus Based Immunosuppression Regimen in Stable Pediatric Liver Transplant Patients

Who this might be right for
Liver Transplantation
Astellas Pharma Inc 19
Not applicableStudy completedNCT07250919
What this trial is testing

Donor and Recipient Mismatch in Liver Transplantation

Who this might be right for
Patient SurvivalGraft SurvivalLiver Disease (Alcoholic or Not)+1 more
University of Jena 1,146
Post-approval studies (Phase 4)Study completedNCT01958190
What this trial is testing

Study Comparing in Livertransplantation Recipients With Tacrolimus Alone Versus Tacrolimus&Sirolimus

Who this might be right for
Liver Disease
Foundation for Liver Research 196
Large-scale testing (Phase 3)Study completedNCT01150097
What this trial is testing

Extension Study to Evaluate the Long-term Efficacy and Safety of Everolimus in Liver Transplant Recipients

Who this might be right for
Liver Transplant Recipient
Novartis Pharmaceuticals 284
Not applicableLooking for participantsNCT07001085
What this trial is testing

CtDNA Monitoring in Patients With HCC and mCRC

Who this might be right for
HCC - Hepatocellular CarcinomaColorectal Cancer Metastatic
Medical University of Warsaw 300
Not applicableStudy completedNCT01936519
What this trial is testing

Conversion to Everolimus From Calcineurin Inhibitor With Mycophenolic Acid: Impact on Long Term Renal Function in Liver Transplantation.

Who this might be right for
ImmunosuppressionRenal Failure
Milton S. Hershey Medical Center 24
Large-scale testing (Phase 3)Study completedNCT02118896
What this trial is testing

Study to Ascertain if Prolonged Release Tacrolimus (FK506E - MR4) is Safe and Effective When Used in the Long Term and in Combination With Other Immunosuppressive Drugs in Patients Who Have Received a Transplant

Who this might be right for
Heart TransplantationLiver TransplantationKidney Transplantation
Astellas Pharma Europe Ltd. 850
Not applicableLooking for participantsNCT07778459
What this trial is testing

Expanding HOPE Liver

Who this might be right for
HIV InfectionLiver Transplant
National Institute of Allergy and Infectious Diseases (NIAID) 80
Not applicableUnknownNCT05707520
What this trial is testing

Long-term Benefit of MPA in Liver Transplantation

Who this might be right for
Liver Transplant RejectionImmunosuppressant Adverse Reaction
Third Affiliated Hospital, Sun Yat-Sen University 500
Not applicableStudy completedNCT06290726
What this trial is testing

Long-term Outcomes of Living Donor Liver Transplantations With Anti-HBc (+) Grafts in Pediatric Patients

Who this might be right for
Living Donor Liver Transplantations With Anti-HBc (+) Grafts
Chang Gung Memorial Hospital 204
Not applicableStudy completedNCT01883206
What this trial is testing

CMV Glycoprotein B (gB) Vaccine Long Term Antibody Response

Who this might be right for
Viraemia
University College, London 48
Testing effectiveness (Phase 2)Study completedNCT01294020
What this trial is testing

Study to Compare the Pharmacokinetics of Tacrolimus in Stable Pediatric Allograft Recipients Converted From Prograf® to Advagraf®

Who this might be right for
Intestine TransplantationKidney TransplantationLung Transplantation+2 more
Astellas Pharma Europe Ltd. 81
Not applicableStudy completedNCT01715779
What this trial is testing

Follow-up Study of Patients Who Experienced Thromboembolic Events in the ENABLE Studies

Who this might be right for
Hepatitis C
Novartis 22
Post-approval studies (Phase 4)Study completedNCT00118742
What this trial is testing

Liver Spare the Nephron (STN) Study - A Study of CellCept (Mycophenolate Mofetil) and Sirolimus in Recipients of a Liver Transplant

Who this might be right for
Liver Transplantation
Hoffmann-La Roche 293
Testing effectiveness (Phase 2)Study completedNCT00282243
What this trial is testing

Assess the Pharmacokinetics of a Modified-release Tacrolimus Based Immunosuppression Regimen in Stable Liver Transplant Patients

Who this might be right for
Liver Transplantation
Astellas Pharma Inc 70
Testing effectiveness (Phase 2)Study completedNCT01614665
What this trial is testing

Compare How the Body Absorbs and Processes Two Different Formulations of the Anti-rejection Medication Tacrolimus (Advagraf® or Prograf®) in Children Receiving an Organ Transplant, and How Safe and Effective They Are Over a Longer Period of Time

Who this might be right for
Heart TransplantationKidney TransplantationLiver Transplantation
Astellas Pharma Europe Ltd. 44
Not applicableLooking for participantsNCT07654855
What this trial is testing

Long-term Safety of Eplontersen Treated aTTR Patients and in Liver Transplant and Severely Hepatic Impaired Subpopulations

Who this might be right for
Transthyretin AmyloidosisTransthyretin Amyloidosis With CardiomyopathyTransthyretin Amyloidosis With Polyneuropathy
AstraZeneca 320
Next Page